GCVRZ
Sanofi Contingent Value Rights
GCVRZ
GCVRZ
Delisted
GCVRZ was delisted on the 3rd of March, 2020.
103 hedge funds and large institutions have $87.5M invested in Sanofi Contingent Value Rights in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
31% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 16
Holders
103
Holding in Top 10
3
Calls
$17M
Puts
–
Top Buyers
| 1 | +$1.04M | |
| 2 | +$253K | |
| 3 | +$78K | |
| 4 |
HCM
Highbridge Capital Management
New York
|
+$17.7K |
| 5 |
Goldman Sachs
New York
|
+$9.75K |
Top Sellers
| 1 | -$335K | |
| 2 | -$161K | |
| 3 | -$70K | |
| 4 |
TL
TowerView LLC
New York
|
-$58.6K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$57.4K |